- Corporate Officers - P
- Posard Matthew L.
Insider Trading History of Posard Matthew L.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Posard Matthew L. since 2013.
This trader's CIK number is 1543792.
At the time of last reporting, Posard Matthew L. was the Officer of Halozyme Therapeutics, Inc.. (stock ticker symbol HALO).
Also see all insider trading activities at Halozyme Therapeutics, Inc..
Note that in the past
Posard Matthew L. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Talis Biomedical Corp (TLIS) by Posard Matthew L.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | TLIS | 62,500 | $1,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Dermtech, Inc. (DMTK) by Posard Matthew L.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | DMTK | 33,898 | $999,991 | 0 | $0 | 0 | $0 |
| 2020 | DMTK | 0 | $0 | 0 | $0 | 25,696 | $67,331 |
Yearly summary of insider trading at Illumina, Inc. (ILMN) by Posard Matthew L.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | ILMN | 0 | $0 | 51,068 | $2,995,832 | 51,068 | $1,606,217 |
Yearly summary of insider trading at Halozyme Therapeutics, Inc. (HALO) by Posard Matthew L.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | HALO | 0 | $0 | 29,881 | $1,689,293 | 0 | $0 |
| 2022 | HALO | 0 | $0 | 30,000 | $1,706,550 | 0 | $0 |
Yearly summary of insider trading at Nautilus Biotechnology, Inc. (NAUT) by Posard Matthew L.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | NAUT | 50,000 | $225,500 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Posard Matthew L.:
1. Talis Biomedical Corp (TLIS)
2. Dermtech, Inc. (DMTK)
3. Illumina, Inc. (ILMN)
4. Halozyme Therapeutics, Inc. (HALO)
5. Nautilus Biotechnology, Inc. (NAUT)
Table 1. Insider trading of Talis Biomedical Corp (TLIS) by Posard Matthew L.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-02-17 | TLIS | Buy | 62,500 | 16.00 | 1,000,000 |
Table 2. Insider trading of Dermtech, Inc. (DMTK) by Posard Matthew L.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-01-11 | DMTK | Buy | 33,898 | 29.50 | 999,991 |
| 2020-04-29 | DMTK | Option Ex | 9,702 | 6.94 | 67,331 |
| 2019-12-31 | DMTK | Option Ex | 15,994 | .00 | 0 |
Table 3. Insider trading of Illumina, Inc. (ILMN) by Posard Matthew L.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-05-30 | ILMN | Option Ex | 2,836 | 37.04 | 105,045 |
| 2013-05-30 | ILMN | Sale | 2,836 | 70.80 | 200,788 |
| 2013-04-11 | ILMN | Option Ex | 48,232 | 31.12 | 1,501,172 |
| 2013-04-11 | ILMN | Sale | 48,232 | 57.95 | 2,795,044 |
Table 4. Insider trading of Halozyme Therapeutics, Inc. (HALO) by Posard Matthew L.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-08-12 | HALO | Sale | 10,000 | 55.72 | 557,230 |
| 2024-08-13 | HALO | Sale | 10,000 | 56.19 | 561,930 |
| 2024-08-14 | HALO | Sale | 9,881 | 57.70 | 570,133 |
| 2022-12-02 | HALO | Sale | 10,000 | 58.80 | 588,000 |
| 2022-12-05 | HALO | Sale | 10,000 | 55.74 | 557,370 |
| 2022-12-06 | HALO | Sale | 10,000 | 56.12 | 561,180 |
Table 5. Insider trading of Nautilus Biotechnology, Inc. (NAUT) by Posard Matthew L.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-12-01 | NAUT | Buy | 30,000 | 4.47 | 134,100 |
| 2021-11-30 | NAUT | Buy | 20,000 | 4.57 | 91,400 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Posard Matthew L.
(Officer of Halozyme Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.